A Review of RADIANCE-HTN TRIO cohort

RADIANCE-HTN SOLO: primary outcomes of renal denervation - session webcastПодробнее

RADIANCE-HTN TRIO: key takeaways and implications for the treatment of hypertension - EuroPCR 2021Подробнее

Study Update of the ReCor Medical Paradise System in Clinical Hypertension (RADIANCE-HTN)Подробнее

A review of the RADIANCE-HTN global clinical trial programme: a focus on the TRIO cohort - #EuroPCRПодробнее

Crossover results from the RADIANCE-HTN SOLO trialПодробнее

RADIANCE-HTN TRIO - Primary Analysis and ResultПодробнее

EuroPCR 22: Patient-Level Pooled Analysis of Ultrasound RDN in radiance-HTN SOLO & TrioПодробнее

RADIANCE-HTN-TRIO: what does this mean for the treatment of hypertension? - EuroPCR 2021Подробнее

The Radiance HTN-SOLO results - A sound choice for Renal DenervationПодробнее

Latest evidence from the RADIANCE-HTN trial and the path to clinical adoption - PCR e-Course 2020Подробнее

Renal Denervation for Hypertension: State of the Science in 2021Подробнее

Recor EuroPCR 2024 SymposiumПодробнее

TCT 2021: RADIANCE-HTN: 6Mo Outcomes of RDN Vs a Sham Procedure for Resistant HypertensionПодробнее

How does Ultrasound Renal Denervation fit into Hypertension treatment?Подробнее

Ultrasound renal denervation: RADIANCE-HTN SOLO results - EuroPCR 2019Подробнее

PCR e-Course 2020: Crossover Results From The RADIANCE-HTN SOLO Trial — Dr Ajay J KirtaneПодробнее

uRDN now - The third pillar for hypertension treatment - EuroPCR 2024Подробнее